CCMH
ACOR

Cornerstone Capital Management Holdings’s Acorda Therapeutics ACOR Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$520K Sell
202
-10
-5% -$28.4K ﹤0.01% 1004
2017
Q3 		$601K Sell
212
-329
-61% -$867K ﹤0.01% 1021
2017
Q2 		$1.28M Buy
541
+340
+169% +$674K 0.01% 846
2017
Q1 		$507K Sell
201
-415
-67% -$1.19M ﹤0.01% 1059
2016
Q4 		$1.39M Sell
616
-340
-36% -$808K 0.01% 873
2016
Q3 		$2.4M Sell
956
-785
-45% -$2.34M 0.02% 699
2016
Q2 		$5.33M Buy
1,741
+597
+52% +$1.94M 0.04% 438
2016
Q1 		$3.63M Buy
1,144
+244
+27% +$1.01M 0.03% 556
2015
Q4 		$4.62M Sell
900
-187
-17% -$817K 0.04% 475
2015
Q3 		$3.46M Buy
1,087
+39
+4% +$151K 0.03% 540
2015
Q2 		$4.19M Buy
1,048
+401
+62% +$1.55M 0.04% 483
2015
Q1 		$2.58M Sell
647
-184
-22% -$843K 0.02% 645
2014
Q4 		$4.08M Sell
831
-85
-9% -$365K 0.04% 463
2014
Q3 		$3.72M Buy
916
+88
+11% +$330K 0.04% 477
2014
Q2 		$3.35M Buy
828
+721
+674% +$2.94M 0.04% 520
2014
Q1 		$487K Sell
107
-875
-89% -$3.54M 0.01% 988
2013
Q4 		$3.44M Buy
982
+81
+9% +$316K 0.04% 487
2013
Q3 		$3.7M Sell
901
-73
-7% -$314K 0.04% 463
2013
Q2 		$3.86M Buy
+974
New +$4.01M 0.05% 445

Other funds holding ACOR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cornerstone Capital Management Holdings's ACOR Position: Q4 2017 in Review

Cornerstone Capital Management Holdings reduced its Acorda Therapeutics (ACOR) stake by 4.7% in Q4 2017, selling an estimated $28.4K and leaving 202 shares worth $520K. The position accounts for ﹤0.01% of the portfolio, ranked #1004.

Cornerstone Capital Management Holdings first reported a position in ACOR in Q2 2013 and has held it in 19 quarters since. The position peaked at $5.33M in Q2 2016. 150 funds tracked by Wall St. Rank hold ACOR as of Q4 2017.

  • Cornerstone Capital Management Holdings held 202 shares of Acorda Therapeutics worth $520K as of Q4 2017.
  • Cornerstone Capital Management Holdings sold 10 Acorda Therapeutics shares in Q4 2017, an estimated $28.4K.
  • Acorda Therapeutics made up ﹤0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #1004 holding.
  • Cornerstone Capital Management Holdings first reported a position in Acorda Therapeutics in Q2 2013 and has held it in 19 quarters since.
  • Cornerstone Capital Management Holdings's Acorda Therapeutics position peaked at $5.33M in Q2 2016.
  • 150 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.